Navigation Links
Improved cancer treatments the focus of $6 milion research project
Date:9/6/2012

Research into the natural process of cell death, its role in the development of blood cancers and harnessing cell death to improve cancer therapies has seen a Walter and Eliza Hall Institute research team from Melbourne, Australia, awarded a grant of more than $6 million by the US-based Leukemia & Lymphoma Society.

The grant of $1.25 million a year for five years was one of four awarded through the Leukemia & Lymphoma Society's Specialized Center of Research (SCOR) program.

The Walter and Eliza Hall Institute team was the only team outside the United States awarded a SCOR program grant.

Professor Jerry Adams, director of the SCOR program and joint head of the Institute's Molecular Genetics of Cancer division, said the research team had been investigating apoptosis, the natural process of cell death, for more than two decades.

"Our bodies make billions of blood cells every day, and, to make room, billions of other blood cells must undergo apoptosis," Professor Adams said. "If some cells fail to die when they should, they can develop into leukaemia, lymphoma or multiple myeloma. We are studying how impaired apoptosis contributes to the development of blood cell cancers and renders the malignant cells more resistant to current therapies."

In the late 1980s and early 1990s, institute researchers discovered that the Bcl-2 protein family promoted the development of blood cancers by preventing the death of cancerous cells and also helped cancer cells resist anti-cancer therapies. This put apoptosis centre stage in cancer research.

"Nearly all anti-cancer therapies act through the Bcl-2 apoptotic switch," Professor Adams said, "but they affect it indirectly. To improve cancer treatments we are investigating the effectiveness of new drugs, used either alone or in combination with other therapies, that directly engage the apoptotic machinery and flip the cell death switch. We have already identified some promising drug candidates and this new funding will allow us to further investigate their effectiveness and the usefulness of other new anti-cancer agents."


'/>"/>
Contact: Ms. Penny Fannin
fannin@wehi.edu.au
Walter and Eliza Hall Institute
Source:Eurekalert  

Related medicine news :

1. 30-day mortality after AMI drops with improved treatment
2. PSA Testing Linked to Improved Prostate Cancer Survival
3. Prostate cancer survival rates improved since introduction of PSA testing
4. East meets West to bring improved sanitation and hygiene practices to Vietnam, Cambodia
5. By studying animal health, researchers find improved ways for developing, testing cancer therapies
6. Health care organizations quest for reduced costs and improved quality
7. HCOs find risks & opportunities in quest for reduced costs & improved quality
8. Is Improved Vaccine Causing Whooping Cough Outbreaks?
9. Expanding Medicaid to low-income adults leads to improved health, fewer deaths
10. Analysis of KRYSTEXXA phase III data demonstrates improved health-related quality of life and physical function in refractory chronic gout patients
11. PaleoMeal Organic Whey Protein Formula Improved According to Rockwell Nutrition
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Improved cancer treatments the focus of $6 milion research project
(Date:12/8/2016)... ... 2016 , ... David J. Dykeman , Ginger Pigott , and ... speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport Beach in California. ... firm’s global Life Sciences & Medical Technology Group have been featured speakers at every ...
(Date:12/8/2016)... Tampa, Fla (PRWEB) , ... December 08, 2016 ... ... offering smarter modes of access for customers and employees that are both engaging ... ChangeGear 7 with Service Smart Technology, the software company revealed today its plans ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
(Date:12/8/2016)... ... December 08, 2016 , ... STAT courier is pleased ... a convenient service for Texas, they are expanding their presence in Dallas. One of ... spree that will bring new jobs to the Dallas and Forth Worth market. STAT ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are encouraged to ... mind, SIGVARIS has created a new line of anti-embolism stockings to help prevent ... the benefits of graduated compression when transitioning from recovery to early rehabilitation. , ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... AMSTERDAM , December 8, 2016 Information ... TM metrics in Scopus , the world,s largest ... free access to comprehensive metrics for journals from over 5,000 publishers. ... publish, which journals to subscribe to and when to adjust a ... , , ...
(Date:12/8/2016)... 2016 According to the research report, ... is expected to be worth US$9.7 bn by the ... Between the forecast years of 2016 and 2024, the global ... The leading players operating in the global diabetes injection pens ... plc., Biocon Ltd., and Sanofi S.A. Transparency Market Research reports ...
(Date:12/8/2016)... 2016 According to a new market research report ... Therapeutic (Pain, Insulin)), End Use (Sports, Fitness, RPM), Type (Smart watch, Patch), ... global market, in terms of value, is projected to reach 12.14 Billion ... 18.0% during the forecast period. Continue Reading ... ...
Breaking Medicine Technology: